newdrugapprovals.org
FDA approves new treatment Endari (L-glutamine oral powder) for sickle cell disease
FDA approves new treatment for sickle cell disease 07/07/2017 The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle…